RESEARCH LINES > Proctology
A high percentage of people with HIV are coinfected with human papilloma virus (HPV).
HPV is the most common of all sexually transmitted infections: 75% of the general population will acquire it at some point in their lifetime. HPV is generally eliminated by the body naturally without causing any harm. However, in people with weakened immune systems such as those who are HIV-positive, HPV is associated with the development of precursor lesions which, in the worst cases, can go on to become cancer, primarily of the cervix or anus.
Therefore, people with HIV require specific follow-up. Since 2005, the Foundation has provided the service of detection, diagnosis, monitoring and treatment of HPV in seropositive men and women regardless of their sexual practice.
In fact, Germans Trias i Pujol University Hospital was one of the first hospitals in Europe to offer regular proctology consultations to HIV-positive patients and to treat the pre-cancerous lesions detected by infrared coagulator, a technique that allows the lesion to be removed on an outpatient basis, without the need for hospital admission or surgical intervention.